Physicians and dietitians question overeating theories
Updated
Updated · The New York Times · May 4
Physicians and dietitians question overeating theories
6 articles · Updated · The New York Times · May 4
The debate comes as nearly two in five Americans have obesity, about one in eight have diabetes, and US spending on GLP-1 drugs rose roughly fivefold to more than $70bn by 2023.
Critics of the standard view argue health problems may stem less from excessive pleasure than from not enjoying food enough, challenging research that blames hyperpalatable foods and dopamine-driven cravings.
The article highlights a possible rethink of dieting and weight-loss science, which often treats restraint and self-denial as the answer to overeating and long-term weight gain.
With GLP-1s silencing cravings, must the food industry now redesign its entire 'hyperpalatable' product strategy?
If obesity stems from not enjoying food enough, why do drugs that dull food's appeal work so effectively?